Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

KALA

KALA BIO (KALA)

KALA BIO Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:KALA
日付受信時刻ニュースソース見出しコード企業名
2025/01/0810 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2025/01/0810 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2025/01/0810 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2025/01/0321 : 07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KALAKALA BIO Inc
2025/01/0106 : 13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KALAKALA BIO Inc
2024/12/3023 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2024/12/3022 : 00GlobeNewswire Inc.KALA BIO Announces $10,750,000 Private PlacementNASDAQ:KALAKALA BIO Inc
2024/11/2722 : 00GlobeNewswire Inc.KALA BIO to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
2024/11/1506 : 49Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KALAKALA BIO Inc
2024/11/1306 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
2024/11/1222 : 00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
2024/09/2605 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2024/09/0705 : 06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:KALAKALA BIO Inc
2024/08/0821 : 00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:KALAKALA BIO Inc
2024/08/0621 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2024/08/0621 : 00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
2024/08/0113 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KALAKALA BIO Inc
2024/08/0105 : 08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KALAKALA BIO Inc
2024/07/2605 : 10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KALAKALA BIO Inc
2024/07/1806 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
2024/07/1706 : 34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KALAKALA BIO Inc
2024/07/0909 : 54Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KALAKALA BIO Inc
2024/06/2721 : 00GlobeNewswire Inc.KALA BIO Announces $12,500,000 Private PlacementNASDAQ:KALAKALA BIO Inc
2024/06/1309 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/06/1309 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/06/1309 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/06/1305 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
2024/06/0409 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/06/0409 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
2024/06/0409 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
 Showing the most relevant articles for your search:NASDAQ:KALA

最近閲覧した銘柄

Delayed Upgrade Clock